BioCentury
ARTICLE | Company News

Karo Bio, Novalon deal

May 15, 2000 7:00 AM UTC

KARO completed its previously announced acquisition of Novalon in a stock transaction (see BioCentury, April 3). Novalon is developing BioKeys, small proteins that bind to protein targets such as nucl...